Moderna Inc
NASDAQ:MRNA
Moderna Inc
Inventory
Moderna Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Moderna Inc
NASDAQ:MRNA
|
Inventory
$295m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Inventory
$4.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Inventory
$1.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-1%
|
|
Amgen Inc
NASDAQ:AMGN
|
Inventory
$8.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
24%
|
CAGR 10-Years
11%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Inventory
$813.1m
|
CAGR 3-Years
40%
|
CAGR 5-Years
43%
|
CAGR 10-Years
54%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Inventory
$2.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
18%
|
CAGR 10-Years
41%
|
See Also
What is Moderna Inc's Inventory?
Inventory
295m
USD
Based on the financial report for Mar 31, 2024, Moderna Inc's Inventory amounts to 295m USD.
What is Moderna Inc's Inventory growth rate?
Inventory CAGR 3Y
-16%
Over the last year, the Inventory growth was -60%. The average annual Inventory growth rates for Moderna Inc have been -16% over the past three years .